AGILENT TECHNOLOGIES, INC. (A) Operating Margin
- Operating margin · 12 months: Value 22.23%; Formula and calculation Operating income / revenue. Period ending 2026-07-31..
Operating margin
Overview →Financial period ending 2026-07-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 22.23% | Operating income / revenue. Period ending 2026-07-31. $1.64B ÷ $7.37B × 100 ≈ 22.23% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 1.64B USD | Operating Income (Loss) |
| Revenue | 7.37B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 3.40B USD | Cost of Goods and Services Sold |
| Research and development | 485.00M USD | Research and Development Expense |
| Selling, general and administration | 1.84B USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-07-31 | $1.64B | $7.37B | $3.40B | $485.00M | $1.84B | 22.23% |
| 2026-04-30 | $1.55B | $7.23B | $3.42B | $473.00M | $1.79B | 21.50% |
| 2026-01-31 | $1.46B | $7.07B | $3.38B | $459.00M | $1.77B | 20.61% |
| 2025-10-31 | $1.48B | $6.95B | $3.31B | $455.00M | $1.71B | 21.29% |
| 2025-07-31 | $1.44B | $6.79B | $3.22B | $447.00M | $1.68B | 21.27% |
| 2025-04-30 | $1.42B | $6.63B | $3.09B | $463.00M | $1.66B | 21.38% |
| 2025-01-31 | $1.48B | $6.53B | $3.01B | $464.00M | $1.58B | 22.65% |
| 2024-10-31 | $1.49B | $6.51B | $2.98B | $479.00M | $1.57B | 22.86% |
| 2024-07-31 | $1.49B | $6.50B | $2.96B | $482.00M | $1.56B | 22.90% |
| 2024-04-30 | $1.29B | $6.59B | $3.25B | $473.00M | $1.58B | 19.54% |
| 2024-01-31 | $1.31B | $6.74B | $3.33B | $486.00M | $1.61B | 19.42% |
| 2023-10-31 | $1.35B | $6.83B | $3.37B | $481.00M | $1.63B | 19.76% |
| 2023-07-31 | $1.41B | $6.99B | $3.43B | $486.00M | $1.66B | 20.20% |
| 2023-04-30 | $1.69B | $7.04B | $3.20B | $484.00M | $1.67B | 24.02% |
| 2023-01-31 | $1.67B | $6.93B | $3.15B | $473.00M | $1.64B | 24.07% |
| 2022-10-31 | $1.62B | $6.85B | $3.13B | $467.00M | $1.64B | 23.63% |
| 2022-07-31 | $1.54B | $6.66B | $3.05B | $464.00M | $1.60B | 23.16% |
| 2022-04-30 | $1.47B | $6.53B | $3.00B | $461.00M | $1.59B | 22.48% |
| 2022-01-31 | $1.40B | $6.45B | $2.97B | $455.00M | $1.63B | 21.64% |
| 2021-10-31 | $1.35B | $6.32B | $2.91B | $441.00M | $1.62B | 21.32% |
| 2021-07-31 | $1.25B | $6.14B | $2.85B | $427.00M | $1.62B | 20.37% |
| 2021-04-30 | $1.15B | $5.82B | $2.71B | $406.00M | $1.56B | 19.68% |
| 2021-01-31 | $959.00M | $5.53B | $2.58B | $494.00M | $1.50B | 17.34% |
| 2020-10-31 | $846.00M | $5.34B | $2.50B | $495.00M | $1.50B | 15.85% |
| 2020-07-31 | $797.00M | $5.22B | $2.44B | $495.00M | $1.49B | 15.26% |
| 2020-04-30 | $792.00M | $5.24B | $2.43B | $504.00M | $1.51B | 15.13% |
| 2020-01-31 | $906.00M | $5.24B | $2.42B | $406.00M | $1.51B | 17.30% |
| 2019-10-31 | $941.00M | $5.16B | $2.36B | $404.00M | $1.46B | 18.23% |
| 2019-07-31 | $959.00M | $5.09B | $2.31B | $404.00M | $1.42B | 18.84% |
| 2019-04-30 | $955.00M | $5.02B | $2.27B | $400.00M | $1.40B | 19.03% |
| 2019-01-31 | $949.00M | $4.99B | $2.26B | $393.00M | $1.38B | 19.03% |
| 2018-10-31 | $928.00M | $4.91B | $2.23B | $385.00M | $1.37B | 18.88% |
| 2018-07-31 | $912.00M | $4.81B | (m) | $370.00M | $1.34B | 18.96% |
| 2018-04-30 | $888.00M | $4.72B | (m) | $360.00M | $1.31B | 18.81% |
| 2018-01-31 | $874.00M | $4.62B | (m) | $353.00M | $1.28B | 18.93% |
| 2017-10-31 | $841.00M | $4.47B | (m) | $339.00M | $1.23B | 18.81% |
| 2017-07-31 | $791.00M | $4.39B | (m) | $334.00M | $1.23B | 18.00% |
| 2017-04-30 | $736.00M | $4.32B | (m) | $333.00M | $1.23B | 17.02% |
| 2017-01-31 | $666.00M | $4.24B | (m) | $330.00M | $1.24B | 15.70% |
| 2016-10-31 | $615.00M | $4.20B | (m) | $329.00M | $1.25B | 14.64% |
| 2016-07-31 | $588.00M | $4.13B | (m) | $327.00M | $1.23B | 14.25% |
| 2016-04-30 | $586.00M | $4.10B | (m) | $320.00M | $1.21B | 14.31% |
| 2016-01-31 | $562.00M | $4.04B | (m) | $320.00M | $1.18B | 13.91% |
| 2015-10-31 | $522.00M | $4.04B | (m) | $330.00M | $1.19B | 12.93% |
| 2015-07-31 | $848.00M | $6.98B | (m) | $706.00M | $2.05B | 12.15% |
| 2015-04-30 | $835.00M | $6.97B | (m) | $713.00M | $2.04B | 11.97% |
| 2015-01-31 | $822.00M | $7.00B | (m) | $719.00M | $2.06B | 11.74% |
| 2014-10-31 | $831.00M | $6.98B | (m) | $719.00M | $2.04B | 11.90% |
| 2014-07-31 | $942.00M | $6.89B | (m) | $703.00M | $1.96B | 13.66% |
| 2014-04-30 | $949.00M | $6.78B | (m) | $697.00M | $1.90B | 14.00% |
| 2014-01-31 | $952.00M | $6.78B | (m) | $702.00M | $1.88B | 14.04% |
| 2013-10-31 | $951.00M | $6.78B | (m) | $704.00M | $1.88B | 14.02% |
| 2013-07-31 | $944.00M | $6.83B | (m) | $709.00M | $1.90B | 13.82% |
| 2013-04-30 | $978.00M | $6.90B | (m) | $700.00M | $1.91B | 14.17% |
| 2013-01-31 | $1.06B | $6.90B | (m) | $685.00M | $1.86B | 15.43% |
| 2012-10-31 | $1.12B | $6.86B | (m) | $668.00M | $1.82B | 16.32% |
| 2012-07-31 | $1.15B | $6.82B | (m) | $653.00M | $1.80B | 16.92% |
| 2012-04-30 | $1.17B | $6.79B | (m) | $653.00M | $1.79B | 17.17% |
| 2012-01-31 | $1.13B | $6.73B | (m) | $652.00M | $1.80B | 16.80% |
| 2011-10-31 | $1.07B | $6.62B | (m) | $649.00M | $1.81B | 16.19% |
| 2011-07-31 | $961.00M | $6.46B | (m) | $645.00M | $1.84B | 14.87% |
| 2011-04-30 | $795.00M | $6.16B | (m) | $637.00M | $1.84B | 12.91% |
| 2011-01-31 | $683.00M | $5.75B | (m) | $622.00M | $1.78B | 11.88% |
| 2010-10-31 | $566.00M | $5.44B | (m) | $612.00M | $1.75B | 10.40% |
| 2010-07-31 | $434.00M | $5.04B | (m) | $603.00M | $1.69B | 8.62% |
| 2010-04-30 | $318.00M | $4.71B | (m) | $602.00M | $1.62B | 6.75% |
| 2010-01-31 | $117.00M | $4.53B | (m) | $622.00M | $1.62B | 2.58% |
| 2009-10-31 | $47.00M | $4.48B | (m) | $642.00M | $1.60B | 1.05% |
| 2009-07-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-04-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-01-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-10-31 | $795.00M | $5.77B | (m) | $704.00M | $1.70B | 13.77% |
| 2008-07-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2007-10-31 | $584.00M | $5.42B | (m) | $685.00M | $1.70B | 10.77% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WATERS CORP /DE/ (WAT) | United States | $42.297B | 224.28 |
| ILLUMINA, INC. (ILMN) | United States | $41.357B | 32.37 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |